Similar articles

• Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.

  Zaagsma J, Meems L, Boorsma M. Zaagsma J, et al. Naunyn Schmiedebergs Arch Pharmacol. 1977 May;298(1):29-36. doi: 10.1007/BF00510983. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 18685 No abstract available.
• Beta-adrenoceptor studies. 2. Effects of alkyl substitution on beta-adrenoceptor blocking, antiarrhythmic, and local anesthetic activities of 1,1'-(o-phenylenedioxy)bis(3-isopropylamino-2-propanol).

  Zaagsma J, Nauta WT. Zaagsma J, et al. J Med Chem. 1977 Apr;20(4):527-31. doi: 10.1021/jm00214a013. J Med Chem. 1977. PMID: 15113
• Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.

  Mokrý P, Zemanová M, Csöllei J, Racanská E, Tumová I. Mokrý P, et al. Pharmazie. 2003 Jan;58(1):18-21. Pharmazie. 2003. PMID: 12622246
• The antiarrhythmic properties of beta-adrenoceptor antagonists.

  IJzerman AP, Soudijn W. IJzerman AP, et al. Trends Pharmacol Sci. 1989 Jan;10(1):31-6. doi: 10.1016/0165-6147(89)90104-1. Trends Pharmacol Sci. 1989. PMID: 2574509 Review.
• The need to redefine membrane stabilizing activity of beta-adrenergic receptor antagonists.

  Smith HJ. Smith HJ. J Mol Cell Cardiol. 1982 Sep;14(9):495-500. doi: 10.1016/0022-2828(82)90210-3. J Mol Cell Cardiol. 1982. PMID: 6129327 Review. No abstract available.